Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-05-25 21:02 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,098,713 vol |
1,098,713 | |
Filed 2020-05-24 17:44 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,098,713 vol |
||
Filed 2020-05-24 18:24 Tx date 2020-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$4,468
+89,372 vol $0.05 each |
89,372 | |
Filed 2020-05-24 17:44 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,098,713 vol |
1,098,713 | |
Filed 2020-05-24 17:42 Tx date 2019-01-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-05-24 17:39 Tx date 2020-05-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$65,922
+1,098,713 vol $0.06 each |
1,198,713 | |
Filed 2020-05-24 17:39 Tx date 2020-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
+100,000 vol |
||
Filed 2020-05-24 17:39 Tx date 2020-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
+100,000 vol |
100,000 | |
Filed 2020-05-24 17:37 Tx date 2019-01-14 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Benjamin Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|